Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
- PMID: 26840229
- PMCID: PMC4740492
- DOI: 10.1371/journal.pone.0147470
Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
Erratum in
-
Correction: Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity.PLoS One. 2016 Jul 12;11(7):e0159470. doi: 10.1371/journal.pone.0159470. eCollection 2016. PLoS One. 2016. PMID: 27403661 Free PMC article.
Abstract
Alzheimer´s disease is the most prominent type of dementia and currently no causative treatment is available. According to recent studies, oligomeric species of the amyloid beta (Aβ) peptide appear to be the most toxic Aβ assemblies. Aβ monomers, however, may be not toxic per se and may even have a neuroprotective role. Here we describe a competitive mirror image phage display procedure that allowed us to identify preferentially Aβ1-42 monomer binding and thereby stabilizing peptides, which destabilize and thereby eliminate toxic oligomer species. One of the peptides, called Mosd1 (monomer specific d-peptide 1), was characterized in more detail. Mosd1 abolished oligomers from a mixture of Aβ1-42 species, reduced Aβ1-42 toxicity in cell culture, and restored the physiological phenotype in neuronal cells stably transfected with the gene coding for human amyloid precursor protein.
Conflict of interest statement
Figures
References
-
- Organization WH. Dementia: A Public Health Priority: World Health Organization; 2012.
-
- Ritchie K, Lovestone S. The dementias. Lancet. 2002;360(9347):1759–66. Epub 2002/12/14. . - PubMed
-
- Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 1999;399(6738 Suppl):A23–31. Epub 1999/07/07. . - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
